Storia in 3 fonti

The next goal for weight loss drugs? Fewer injections

Pfizer and Amgen are working on new GLP-1 shots designed to be taken once a month rather than weekly.

Raccontata da

nbcnews.com

inews.co.uk

medpagetoday.com

Confronto fonti

3 prospettive sulla stessa storia

AI · summaries

nbcnews.comStai leggendo1 mesi fa

The next goal for weight loss drugs? Fewer injections

Pfizer and Amgen are working on new GLP-1 shots designed to be taken once a month rather than weekly.

originale

medpagetoday.com1 mesi fa

Monthly GLP-1 for Obesity Promising as More Manageable Alternative

Less frequent dosing could support better long-term adherence, says researcher

Leggi questa versione → originale

inews.co.uk1 mesi fa

Another weight-loss drug revolution is coming - and it could be cheaper than jabs

Novo Nordisk launches semaglutide pills in UK 2026; 70-80% of US users never tried injectable Wegovy. Oral form removes injection barriers at lower cost, but strict empty-stomach dosing and lower efficacy (14% vs 19-20%) limit real adoption.

Leggi questa versione → originale

Timeline cronologica

sabato 6 giugno 2026·nbcnews.com
The next goal for weight loss drugs? Fewer injections
Pfizer and Amgen are working on new GLP-1 shots designed to be taken once a month rather than weekly.
domenica 7 giugno 2026·inews.co.uk
Another weight-loss drug revolution is coming - and it could be cheaper than jabs
Slimming pills that cause 14 per cent weight loss are about to be approved in the UK
lunedì 8 giugno 2026·medpagetoday.com
Monthly GLP-1 for Obesity Promising as More Manageable Alternative
Less frequent dosing could support better long-term adherence, says researcher